IRIS Accounts Production v24.3.0.553 11996802 Board of Directors 1.6.23 31.5.24 31.5.24 false true false false true false A Ordinary 1.00000 B Ordinary 1.00000 C Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh119968022023-05-31119968022024-05-31119968022023-06-012024-05-31119968022022-05-31119968022022-06-012023-05-31119968022023-05-3111996802ns15:EnglandWales2023-06-012024-05-3111996802ns14:PoundSterling2023-06-012024-05-3111996802ns10:Director12023-06-012024-05-3111996802ns10:PrivateLimitedCompanyLtd2023-06-012024-05-3111996802ns10:SmallEntities2023-06-012024-05-3111996802ns10:AuditExempt-NoAccountantsReport2023-06-012024-05-3111996802ns10:SmallCompaniesRegimeForDirectorsReport2023-06-012024-05-3111996802ns10:SmallCompaniesRegimeForAccounts2023-06-012024-05-3111996802ns10:FullAccounts2023-06-012024-05-3111996802ns10:OrdinaryShareClass12023-06-012024-05-3111996802ns10:OrdinaryShareClass22023-06-012024-05-3111996802ns10:OrdinaryShareClass32023-06-012024-05-3111996802ns10:Director22023-06-012024-05-3111996802ns10:Director32023-06-012024-05-3111996802ns10:RegisteredOffice2023-06-012024-05-3111996802ns5:CurrentFinancialInstruments2024-05-3111996802ns5:CurrentFinancialInstruments2023-05-3111996802ns5:ShareCapital2024-05-3111996802ns5:ShareCapital2023-05-3111996802ns5:RetainedEarningsAccumulatedLosses2024-05-3111996802ns5:RetainedEarningsAccumulatedLosses2023-05-3111996802ns5:CostValuation2023-05-3111996802ns10:OrdinaryShareClass12024-05-3111996802ns10:OrdinaryShareClass22024-05-3111996802ns10:OrdinaryShareClass32024-05-31
REGISTERED NUMBER: 11996802 (England and Wales)














UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MAY 2024

FOR

M&M MEDICAL GROUP LIMITED

M&M MEDICAL GROUP LIMITED (REGISTERED NUMBER: 11996802)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


M&M MEDICAL GROUP LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MAY 2024







DIRECTORS: M J Tiffin
P Sayer
P J Chappell





REGISTERED OFFICE: Unit B4 Heol Y Twyn
Talbot Green Business Park
Talbot Green
Rhondda Cynon Taf
CF72 9FG





REGISTERED NUMBER: 11996802 (England and Wales)





ACCOUNTANTS: Sullivans Chartered Accountants
13-14 Gelliwastad Road
Pontypridd
Rhondda Cynon Taf
CF37 2BW

M&M MEDICAL GROUP LIMITED (REGISTERED NUMBER: 11996802)

STATEMENT OF FINANCIAL POSITION
31 MAY 2024

31/5/24 31/5/23
Notes £    £    £    £   
FIXED ASSETS
Investments 4 1,018,133 1,018,133

CURRENT ASSETS
Debtors 5 1,544 2,231

CREDITORS
Amounts falling due within one year 6 2,550 20,742
NET CURRENT LIABILITIES (1,006 ) (18,511 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,017,127

999,622

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 1,017,027 999,522
SHAREHOLDERS' FUNDS 1,017,127 999,622

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 December 2024 and were signed on its behalf by:




M J Tiffin - Director


M&M MEDICAL GROUP LIMITED (REGISTERED NUMBER: 11996802)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024

1. STATUTORY INFORMATION

M&M Medical Group Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

No material uncertainties that may cast significant doubt about the ability of the company to continue as a going concern have been identified by the directors.

Therefore the financial statements have been prepared on a going concern basis.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

M&M MEDICAL GROUP LIMITED (REGISTERED NUMBER: 11996802)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2024

4. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 June 2023
and 31 May 2024 1,018,133
NET BOOK VALUE
At 31 May 2024 1,018,133
At 31 May 2023 1,018,133

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/5/24 31/5/23
£    £   
Amounts owed by group undertakings 1,544 2,231

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/5/24 31/5/23
£    £   
Other creditors 2,550 20,742

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31/5/24 31/5/23
value: £    £   
40 A Ordinary 1 40 40
30 B Ordinary 1 30 30
30 C Ordinary 1 30 30
100 100